Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis.

Maier M, Welt T, Wirth F, Montrasio F, Preisig D, McAfoose J, Vieira FG, Kulic L, Späni C, Stehle T, Perrin S, Weber M, Hock C, Nitsch RM, Grimm J.

Sci Transl Med. 2018 Dec 5;10(470). pii: eaah3924. doi: 10.1126/scitranslmed.aah3924.

PMID:
30518612
2.

High-speed video gait analysis reveals early and characteristic locomotor phenotypes in mouse models of neurodegenerative movement disorders.

Preisig DF, Kulic L, Krüger M, Wirth F, McAfoose J, Späni C, Gantenbein P, Derungs R, Nitsch RM, Welt T.

Behav Brain Res. 2016 Sep 15;311:340-353. doi: 10.1016/j.bbr.2016.04.044. Epub 2016 May 24.

PMID:
27233823
3.

Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study.

Welt T, Kulic L, Hoey SE, McAfoose J, Späni C, Chadha AS, Fisher A, Nitsch RM.

J Alzheimers Dis. 2015;46(4):971-82. doi: 10.3233/JAD-150152.

PMID:
25881909
4.

Amyloid-β peptide-specific DARPins as a novel class of potential therapeutics for Alzheimer disease.

Hanenberg M, McAfoose J, Kulic L, Welt T, Wirth F, Parizek P, Strobel L, Cattepoel S, Späni C, Derungs R, Maier M, Plückthun A, Nitsch RM.

J Biol Chem. 2014 Sep 26;289(39):27080-9. doi: 10.1074/jbc.M114.564013. Epub 2014 Aug 12.

5.

Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.

Kulic L, McAfoose J, Welt T, Tackenberg C, Späni C, Wirth F, Finder V, Konietzko U, Giese M, Eckert A, Noriaki K, Shimizu T, Murakami K, Irie K, Rasool S, Glabe C, Hock C, Nitsch RM.

Transl Psychiatry. 2012 Nov 13;2:e183. doi: 10.1038/tp.2012.109.

6.

Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.

Santuccione AC, Merlini M, Shetty A, Tackenberg C, Bali J, Ferretti MT, McAfoose J, Kulic L, Bernreuther C, Welt T, Grimm J, Glatzel M, Rajendran L, Hock C, Nitsch RM.

Mol Psychiatry. 2013 Mar;18(3):358-68. doi: 10.1038/mp.2012.70. Epub 2012 Jun 12.

PMID:
22688190
7.

The role of cognitive impairment in general functioning in major depression.

Baune BT, Miller R, McAfoose J, Johnson M, Quirk F, Mitchell D.

Psychiatry Res. 2010 Apr 30;176(2-3):183-9. doi: 10.1016/j.psychres.2008.12.001.

PMID:
20138370
8.

Impact of psychiatric and medical comorbidity on cognitive function in depression.

Baune BT, McAfoose J, Leach G, Quirk F, Mitchell D.

Psychiatry Clin Neurosci. 2009 Jun;63(3):392-400. doi: 10.1111/j.1440-1819.2009.01971.x.

9.

The effects of TNF deficiency on age-related cognitive performance.

McAfoose J, Koerner H, Baune BT.

Psychoneuroendocrinology. 2009 May;34(4):615-9. doi: 10.1016/j.psyneuen.2008.10.006. Epub 2008 Nov 22.

PMID:
19028017
10.

Evidence for a cytokine model of cognitive function.

McAfoose J, Baune BT.

Neurosci Biobehav Rev. 2009 Mar;33(3):355-66. doi: 10.1016/j.neubiorev.2008.10.005. Epub 2008 Oct 18. Review.

PMID:
18996146
11.

Exploring visual-spatial working memory: a critical review of concepts and models.

McAfoose J, Baune BT.

Neuropsychol Rev. 2009 Mar;19(1):130-42. doi: 10.1007/s11065-008-9063-0. Epub 2008 Sep 24. Review.

PMID:
18814035
12.

Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis.

Hager K, Kenklies M, McAfoose J, Engel J, Münch G.

J Neural Transm Suppl. 2007;(72):189-93.

PMID:
17982894

Supplemental Content

Loading ...
Support Center